Lastly, we found that low doses of estradiol (0.01 μM) significantly potentiated the ability of progesterone to inhibit expression of sFRP4 transcript in leiomyomas [Fig. 5(c)]. This evidence concerns the gene SFRP4 and leiomyoma.